These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3662105)
1. Primary lower extremity telangiectasias--relationship of size to color. Biegeleisen K Angiology; 1987 Oct; 38(10):760-8. PubMed ID: 3662105 [TBL] [Abstract][Full Text] [Related]
2. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. Kern P; Ramelet AA; Wütschert R; Hayoz D J Vasc Surg; 2007 Jun; 45(6):1212-6. PubMed ID: 17467226 [TBL] [Abstract][Full Text] [Related]
3. Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias. Ramelet AA Dermatol Surg; 2012 May; 38(5):748-51. PubMed ID: 22268802 [TBL] [Abstract][Full Text] [Related]
4. Comparison and sequential study of long pulsed Nd:YAG 1,064 nm laser and sclerotherapy in leg telangiectasias treatment. Levy JL; Elbahr C; Jouve E; Mordon S Lasers Surg Med; 2004; 34(3):273-6. PubMed ID: 15022257 [TBL] [Abstract][Full Text] [Related]
5. Sclerotherapy of telangiectasias or spider veins in the lower limb: A review. Thomson L J Vasc Nurs; 2016 Jun; 34(2):61-2. PubMed ID: 27210454 [No Abstract] [Full Text] [Related]
6. Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel. Schuller-Petrović S; Pavlović MD; Schuller S; Schuller-Lukic B; Adamic M Phlebology; 2013 Sep; 28(6):320-3. PubMed ID: 22865418 [TBL] [Abstract][Full Text] [Related]
7. Therapy for superficial telangiectasias of the lower extremities. Shields JL; Jansen GT J Dermatol Surg Oncol; 1982 Oct; 8(10):857-60. PubMed ID: 7174992 [TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy for superficial venules and telangiectasias of the lower extremities. Goldman PM Dermatol Clin; 1987 Apr; 5(2):369-79. PubMed ID: 3581522 [TBL] [Abstract][Full Text] [Related]
9. Sclerotherapy for telangiectasia of the lower extremity. Sebben JE Dermatol Clin; 1989 Jan; 7(1):129-35. PubMed ID: 2646043 [TBL] [Abstract][Full Text] [Related]
13. Reasons for ulceration after injection treatment of telangiectasia. Bihari I; Magyar E Dermatol Surg; 2001 Feb; 27(2):133-6. PubMed ID: 11207685 [TBL] [Abstract][Full Text] [Related]
14. Sclerotherapy for venous flare. Green AR; Morgan BD Br J Plast Surg; 1985 Apr; 38(2):241-2. PubMed ID: 3986422 [TBL] [Abstract][Full Text] [Related]
15. [Sclerosing treatment of telangiectasis of the lower extremities]. Ouvry P; Arlaud R Phlebologie; 1979; 32(4):365-70. PubMed ID: 545361 [TBL] [Abstract][Full Text] [Related]
16. Compression in the treatment of leg telangiectasia: a preliminary report. Goldman MP; Beaudoing D; Marley W; Lopez L; Butie A J Dermatol Surg Oncol; 1990 Apr; 16(4):322-5. PubMed ID: 2324368 [TBL] [Abstract][Full Text] [Related]
17. A mild sclerosing agent for telangiectasias. Mantse L J Dermatol Surg Oncol; 1985 Sep; 11(9):855. PubMed ID: 4044985 [No Abstract] [Full Text] [Related]
18. Telangiectasia and sclerotherapy. Ouvry PA J Dermatol Surg Oncol; 1989 Feb; 15(2):177-81. PubMed ID: 2644327 [TBL] [Abstract][Full Text] [Related]
19. [The treatment of microvarices, varicosities and telangiectasis in 1992]. Guex JJ Phlebologie; 1992; 45(4):401-4; discussion 405-7. PubMed ID: 1302315 [No Abstract] [Full Text] [Related]